Research published in Natural Chemical Biology reveals that Wellington scientists have had success in developing a vaccine for asthma.
At this stage in the process, the vaccine has proven to prevent lung inflammation in mice. However, scientists will need about five more years of trials before the vaccine is able to be administered to humans. Still, this signals an exciting time for people who suffer from respiratory conditions. If this vaccine is approved, it could be a new, preventative method for dealing with allergies and other diseases, eliminating the need for respiratory inhalers or medications.
Program leader at the Malaghan Institute Franca Rochese explains, ""What we hope is that it's not like having to take drugs for your asthma, where you have to take them all the time."